Sensorion Completes Second Cohort Enrollment in OTOF Gene Therapy Clinical Trial
SENS-501 is a gene therapy candidate being developed to treat a form of congenital deafness linked to mutations in the OTOF (otoferlin) gene.
SENS-501 is a gene therapy candidate being developed to treat a form of congenital deafness linked to mutations in the OTOF (otoferlin) gene.
The Ear Science Institute Australia's project on sensorineural hearing loss treatment will receive research support from MedChem Australia.
The doctors describe a case of a 45-year-old man with asthma who was referred to the ear, nose, and throat department at their hospital after suddenly experiencing hearing loss in one ear while being treated for COVID-19 infection as an inpatient.
The authors point out that coronaviruses, in some cases, can cause peripheral neuropathy, and, ”in theory..COVID-19 could cause auditory neuropathy, a hearing disorder where the cochlea is functioning but transmission along the auditory nerve to the brain is impaired.”
Read MoreMusiciansClinics.com is a resource for those seeking information on a variety of topics related to hearing and hearing loss in musicians. Developed by audiologist-musician Marshall Chasin, AuD, the website offers a large range of resources for guitarists, bass players, violinists, woodwind players, school band teachers, and more.
Read MoreBy the time mice are born, the progenitor cells in the Organ of Corti have finished both proliferation and differentiation, and cannot regenerate if they are damaged—causing permanent hearing loss.
Read More“Our twin discoveries that fruit flies experience age-related hearing loss and that their prior auditory health is controlled by a particular set of genes, is a significant breakthrough. The fact that these genes are conserved in humans will also help to focus future clinical research in humans and thereby accelerate the discovery of novel pharmacological or gene-therapeutic strategies,” says lead-author Joerg Albert.
Read MoreResearchers looked at mice engineered to have progressive hearing loss, and found that their neurotransmitter receptors—responsible for communication between brain cells—exhibited changes in sensory processing regions related to memory.
Read MoreIn the future, scientists may be able to use the data to steer stem cells toward the hair cell lineage, helping to produce the specialized cells they need to test cell replacement approaches for reversing some forms of hearing loss.
Read MoreThe 35-year-old has had profound hearing loss since childhood and wears hearing aids from Sonova brand, Phonak. In Brazil, she is the “first volleyball player with hearing loss to play at professional level and to make it into her country’s national team.”
Read MoreFX-322 is Frequency’s lead product candidate, designed to regenerate auditory sensory hair cells in the cochlea and improve hearing in patients with sensorineural hearing loss (SNHL).
Read MoreIn the hippocampus, synaptic plasticity was chronically impaired by progressive hearing loss. The distribution and density of neurotransmitter receptors in sensory and memory regions of the brain also changed constantly. The stronger the hearing impairment, the poorer were both synaptic plasticity and memory ability.
Read MoreNew research shows that after wearing professionally fit quality hearing aids, a patient’s brain may “re-organize” its auditory processing centers back towards its original state prior to the hearing loss—with corresponding gains in auditory speech perception abilities and improvements in global cognitive function, executive function, processing speed, and visual working memory performance. Anu Sharma discusses the research findings with Douglas Beck.
Read MoreAdapting the “first fit” experience to be more reflective of a patient’s gradual hearing loss experience and providing for a gradual transition allows the auditory system to receive, process, and accept sounds that have been missing.
Read MoreAs hearing aid processing becomes more complex, the area of psychoacoustics becomes increasingly important for understanding exactly what these devices are doing (or trying to do) for your patients’ compromised auditory systems.
Read MoreDr Flexer is an expert in the development and expansion of listening, speaking, and literacy skills in infants and children, including those with all degrees of hearing loss.
Read MoreCROS and BiCROS hearing aids are not the only treatment options for those with unilateral hearing loss. This article reviews other options and potential future avenues for unilateral sensorineural hearing loss and single-sided deafness, as well as for unilateral conductive hearing loss.
Read MoreSenate Bill 976 aims to clear up any miscommunication that may occur during a traffic stop, as the health information will be available to an officer who runs the license plate through their system.
Read More